Literature DB >> 9528832

Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.

B Mayr1, E Pötter, P Goretzki, J Rüschoff, W Dietmaier, C Hoang-Vu, H Dralle, G Brabant.   

Abstract

Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9528832      PMCID： PMC2150093          DOI： 10.1038/bjc.1998.149

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  27 in total

1.  Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.

Authors:  M Santoro; G Chiappetta; A Cerrato; D Salvatore; L Zhang; G Manzo; A Picone; G Portella; G Santelli; G Vecchio; A Fusco
Journal:  Oncogene       Date:  1996-04-18       Impact factor: 9.867

2.  Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo.

Authors:  M Grieco; A Cerrato; M Santoro; A Fusco; R M Melillo; G Vecchio
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

3.  Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.

Authors:  M Santoro; N A Dathan; M T Berlingieri; I Bongarzone; C Paulin; M Grieco; M A Pierotti; G Vecchio; A Fusco
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

4.  RET-deficient mice: an animal model for Hirschsprung's disease and renal agenesis.

Authors:  A Schuchardt; V D'Agati; L Larsson-Blomberg; F Costantini; V Pachnis
Journal:  J Intern Med       Date:  1995-10       Impact factor: 8.989

5.  In vitro irradiation is able to cause RET oncogene rearrangement.

Authors:  T Ito; T Seyama; K S Iwamoto; T Hayashi; T Mizuno; N Tsuyama; K Dohi; N Nakamura; M Akiyama
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

6.  High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.

Authors:  S Klugbauer; E Lengfelder; E P Demidchik; H M Rabes
Journal:  Oncogene       Date:  1995-12-21       Impact factor: 9.867

7.  Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.

Authors:  S M Jhiang; J E Sagartz; Q Tong; J Parker-Thornburg; C C Capen; J Y Cho; S Xing; C Ledent
Journal:  Endocrinology       Date:  1996-01       Impact factor: 4.736

Review 8.  The ret/PTC oncogene in papillary thyroid carcinoma.

Authors:  S M Jhiang; E L Mazzaferri
Journal:  J Lab Clin Med       Date:  1994-03

9.  Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes.

Authors:  S Xing; P A Smanik; M J Oglesbee; J E Trosko; E L Mazzaferri; S M Jhiang
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

10.  Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.

Authors:  M Santoro; N Sabino; Y Ishizaka; T Ushijima; F Carlomagno; A Cerrato; M Grieco; C Battaglia; M L Martelli; C Paulin
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640
View more
  7 in total

1.  Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters.

Authors:  P Jagan Mohan Rao; N V Vardhini; M V S Parvathi; P Balakrishna Murthy; G Sudhakar
Journal:  Tumour Biol       Date:  2014-06-24

2.  Familial isolated parathyroid adenoma in a consanguineous family.

Authors:  C Bergwitz; B Bremer; B Soudah; B Mayr; G Brabant
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

3.  RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations.

Authors:  Mosin S Khan; Qurteeba Qadri; Mudasir J Makhdoomi; Muneer A Wani; Aejaz A Malik; Madiha Niyaz; Shariq R Masoodi; Khurshid I Andrabi; Rauf Ahmad; Syed Mudassar
Journal:  Pathol Oncol Res       Date:  2018-11-22       Impact factor: 3.201

Review 4.  RET proto-oncogene mutations in thyroid carcinomas: clinical relevance.

Authors:  F Pacini; R Elisei; C Romei; A Pinchera
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

5.  RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

Authors:  Cristina Romei; Rossella Elisei
Journal:  Front Endocrinol (Lausanne)       Date:  2012-04-11       Impact factor: 5.555

Review 6.  Mutation Profile of Well-Differentiated Thyroid Cancer in Asians.

Authors:  Young Shin Song; Jung Ah Lim; Young Joo Park
Journal:  Endocrinol Metab (Seoul)       Date:  2015-09

7.  Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.

Authors:  Young Sin Ko; Tae Sook Hwang; Ja Yeon Kim; Yoon-La Choi; Seung Eun Lee; Hye Seung Han; Wan Seop Kim; Suk Kyeong Kim; Kyoung Sik Park
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.